Stay updated on Sage-217 Efficacy in MDD Clinical Trial
Sign up to get notified when there's something new on the Sage-217 Efficacy in MDD Clinical Trial page.

Latest updates to the Sage-217 Efficacy in MDD Clinical Trial page
- Check4 days agoChange DetectedThe page shows a metadata revision: Revision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedLocation sections were reorganized under a single 'Locations' heading and expanded to include multiple states (Arkansas, California, Florida, Georgia, Illinois, Mississippi, Missouri, Nevada, New Jersey, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, and Virginia). The revision version updated from v3.3.2 to v3.3.3.SummaryDifference2%

- Check54 days agoChange DetectedFooter shows Revision: v3.3.2, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedThe government funding status notice banner was removed, and this does not affect the study details or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check75 days agoChange DetectedBiogen is now listed as the sponsor following a transfer from Sage Therapeutics, and the study results were posted (Results First Posted 2023-12-05).SummaryDifference0.3%

- Check104 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference3%

Stay in the know with updates to Sage-217 Efficacy in MDD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sage-217 Efficacy in MDD Clinical Trial page.